No Data
Hong Kong stocks are moving differently | All stocks in the MEDBOT system rose sharply, with MEDBOT-B (02252) at one point gaining over 44%. Shanghai will establish a 10 billion yuan Biomedical industry merger and acquisition Fund.
All MICROPORT stocks are on the rise. As of the time of writing, MEDBOT-B (02252) has surged by 26.05%, trading at 11.66 HKD; MICROPORT (00853) has increased by 11.6%, trading at 6.83 HKD; MICROPORT Neuroscience (02172) is up by 9.14%, trading at 9.79 HKD; and CARDIOFLOW-B (02160) has risen by 2.86%, trading at 0.72 HKD.
With A 33% Price Drop For MicroPort CardioFlow Medtech Corporation (HKG:2160) You'll Still Get What You Pay For
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
HK Stock Special | Microport-related stocks collectively declined. Microport recently sold its properties to alleviate debt pressure.
Microport collectively fell, as of the publication, Microport Robot-B (02252) fell by 6.61%, to 10.46 Hong Kong dollars; Microport Medical (00853) fell by 6.17%, to 7.3 Hong Kong dollars; Microport Neurology (02172) fell by 3.85%, to 9.75 Hong Kong dollars; Heartlinks Medical-B (02160) fell by 5.62%, to 0.84 Hong Kong dollars.
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
Estimating The Fair Value Of MicroPort CardioFlow Medtech Corporation (HKG:2160)
No Data
